Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹787 Cr₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr

What is the latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS is ₹787 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹787 Cr
Mar2024₹-3,906 Cr
Mar2023₹-77 Cr
Mar2022₹-520 Cr
Mar2021₹-442 Cr

How is Cash Flow from Financing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹787 Cr
Positive
Mar2024 ₹-3,906 Cr
Negative
Mar2023 ₹-77 Cr
Negative
Mar2022 ₹-520 Cr
Negative
Mar2021 ₹-442 Cr -

Compare Cash Flow from Financing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,942.9 Cr -1% -2% 31.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,048.0 Cr -0.5% 3.9% 12.1% Stock Analytics
DIVIS LABORATORIES ₹177,179.0 Cr -3.1% -0.1% 0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,804.0 Cr 3.1% 6.7% 45.5% Stock Analytics
CIPLA ₹117,642.0 Cr 1.4% 4.8% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹112,368.0 Cr 0.8% 3.9% 1.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1%

-2%

31.1%

SENSEX

0.7%

4.4%

-5.6%


You may also like the below Video Courses